These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24938375)

  • 21. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Qiao W; Liu H; Guo W; Li P; Deng M
    Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
    Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression.
    Liu C; Qiang J; Deng Q; Xia J; Deng L; Zhou L; Wang D; He X; Liu Y; Zhao B; Lv J; Yu Z; Lei QY; Shao ZM; Zhang XY; Zhang L; Liu S
    Cancer Res; 2021 Dec; 81(23):5919-5934. PubMed ID: 34580061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
    Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
    Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
    Xu J; Müller S; Nannapaneni S; Pan L; Wang Y; Peng X; Wang D; Tighiouart M; Chen Z; Saba NF; Beitler JJ; Shin DM; Chen ZG
    Eur J Cancer; 2012 Jul; 48(11):1682-91. PubMed ID: 22341992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of PD-L1 and prognosis in breast cancer: a meta-analysis.
    Zhang M; Sun H; Zhao S; Wang Y; Pu H; Wang Y; Zhang Q
    Oncotarget; 2017 May; 8(19):31347-31354. PubMed ID: 28430626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma.
    Xu SL; Zeng DZ; Dong WG; Ding YQ; Rao J; Duan JJ; Liu Q; Yang J; Zhan N; Liu Y; Hu QP; Zhang X; Cui YH; Kung HF; Yu SC; Bian XW
    Int J Clin Exp Pathol; 2014; 7(6):2976-86. PubMed ID: 25031716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.
    Oon ML; Thike AA; Tan SY; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):31-41. PubMed ID: 25677743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
    Zhou AL; Wang X; Yu W; Yang L; Wei F; Sun Q; Wang Y; Kou F; Dong R; Ren X; Zhang X
    Pathol Res Pract; 2020 Sep; 216(9):153093. PubMed ID: 32825960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy.
    Kahlert C; Gaitzsch E; Steinert G; Mogler C; Herpel E; Hoffmeister M; Jansen L; Benner A; Brenner H; Chang-Claude J; Rahbari N; Schmidt T; Klupp F; Grabe N; Lahrmann B; Koch M; Halama N; Büchler M; Weitz J
    Ann Surg Oncol; 2012 Dec; 19(13):4193-201. PubMed ID: 22878609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
    Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
    Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.
    Alam M; Ahmad R; Rajabi H; Kharbanda A; Kufe D
    J Biol Chem; 2013 Oct; 288(43):30892-903. PubMed ID: 24043631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
    Yang W; Wang Y; Wang W; Chen Z; Bai G
    Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data.
    Sun X; Zhang G; Nian J; Yu M; Chen S; Zhang Y; Yang G; Yang L; Cheng P; Yan C; Ma Y; Meng H; Wang X; Li JP
    Oncotarget; 2017 Jun; 8(26):43521-43535. PubMed ID: 28388549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis.
    He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX
    J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
    Li T; Su Y; Mei Y; Leng Q; Leng B; Liu Z; Stass SA; Jiang F
    Lab Invest; 2010 Feb; 90(2):234-44. PubMed ID: 20010854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.